Roth Capital Downgrades I-Flow (IFLO) to Hold
More News related to IFLO
- Kimberly-Clark Corporation Completes Tender Offer for I-Flow Corporation
- Kimberly-Clark Corporation Completes Initial Tender Offer for I-Flow Corporation
- Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
- Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation
- I-Flow (IFLO) Posts Q3 EPS of 3c, Beats by 3c
More News related to Downgrades
- JANCO Partners Downgrades Energy Conversion Devices (ENER) to Sell
- Feltl & Co. Downgrades ArcSight (ARST) to Sell
- Credit Suisse Downgrades Comcast (CMCSA) to Neutral
- Citi Downgrades AK Steel (AKS) to Hold
- Citi Downgrades Netflix (NFLX) to Hold
Roth Capital downgrades I-Flow (Nasdaq: IFLO) from Buy to Hold. Price target increased to $12.65 from $10.
To see more analyst ratings on IFLO Click Here.
I-Flow Corporation engages in the design, development, manufacture, and marketing of drug delivery devices and surgical products for post-surgical pain relief and surgical site care.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
PETER PRINCIPLE
JIM PETRILLO on Oct 12, 2009 09:33 AMCEO has reached his apex and fallen off a cliff. Price is way below market value. No Vote recommended.